Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring

BACKGROUND: Standardized and sensitive assays for Epstein Barr Virus (EBV) are needed to define universal cutoff for treatment initiation in allogeneic hematopoietic stem cells transplant recipients. In a context of accreditation and the availability of EBV international standard, we evaluated the A...

Descripción completa

Detalles Bibliográficos
Autores principales: Salmona, Maud, Stefic, Karl, Mahjoub, Nadia, de Fontbrune, Flore Sicre, Maylin, Sarah, Simon, François, Scieux, Catherine, Socié, Gérard, Mazeron, Marie-Christine, LeGoff, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998838/
https://www.ncbi.nlm.nih.gov/pubmed/32014036
http://dx.doi.org/10.1186/s12985-020-1285-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998838/
https://www.ncbi.nlm.nih.gov/pubmed/32014036
http://dx.doi.org/10.1186/s12985-020-1285-7

Ejemplares similares